D2-EPG Study: Evaluation of New Sensing Circuitry and Capture Management

Inclusion Criteria

• •Patients who are scheduled for implantation or replacement of an implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy (CRT) device
• •Patients must have or receive Medtronic transvenous atrial and ventricular leads in association with the scheduled device implant or replacement.